ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Acellular Dermal Matrix Patch Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-31I16778
Home | Market Reports | Beauty & Fitness| Cosmetic Procedures
Global Human Acellular Dermal Matrix Patch Market Research Report 2024
BUY CHAPTERS

Global Human Acellular Dermal Matrix Patch Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-31I16778
Report
November 2025
Pages:147
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zimmer Biomet
Stryker
AlloSource
ConMed
Royal Biologics
Elutia
AbbVie (AlloDerm)
Beijing Jieya Laifu Biotechnology
Jiangxi Kexing Biological Engineering

Human Acellular Dermal Matrix Patch Market

The global Human Acellular Dermal Matrix Patch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Human acellular dermal matrix (HADM) is a allogeneic collagen matrix without immunogenicity, which is more commonly used in surgical treatment. Reconstructive surgery is still searching for various biocompatible materials that can be widely used in surgery.
From a downstream perspective, Plastic Surgery accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Human Acellular Dermal Matrix Patch leading manufacturers including AbbVie (AlloDerm), Zimmer Biomet, Stryker, AlloSource, ConMed, Royal Biologics, Elutia, Beijing Jieya Laifu Biotechnology, Jiangxi Kexing Biological Engineering, etc., dominate supply; the top five capture approximately % of global revenue, with AbbVie (AlloDerm) leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Human Acellular Dermal Matrix Patch market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Human Acellular Dermal Matrix Patch Market Report

Report Metric Details
Report Name Human Acellular Dermal Matrix Patch Market
Segment by Type
  • Standard Dermal Matrix
  • Meshed Dermal Matrix
Segment by Application
  • Plastic Surgery
  • Orthopedics
  • General Surgery
  • Anorectal Department
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie (AlloDerm), Zimmer Biomet, Stryker, AlloSource, ConMed, Royal Biologics, Elutia, Beijing Jieya Laifu Biotechnology, Jiangxi Kexing Biological Engineering
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Human Acellular Dermal Matrix Patch study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Human Acellular Dermal Matrix Patch Market report?

Ans: The main players in the Human Acellular Dermal Matrix Patch Market are AbbVie (AlloDerm), Zimmer Biomet, Stryker, AlloSource, ConMed, Royal Biologics, Elutia, Beijing Jieya Laifu Biotechnology, Jiangxi Kexing Biological Engineering

What are the Application segmentation covered in the Human Acellular Dermal Matrix Patch Market report?

Ans: The Applications covered in the Human Acellular Dermal Matrix Patch Market report are Plastic Surgery, Orthopedics, General Surgery, Anorectal Department, Others

What are the Type segmentation covered in the Human Acellular Dermal Matrix Patch Market report?

Ans: The Types covered in the Human Acellular Dermal Matrix Patch Market report are Standard Dermal Matrix, Meshed Dermal Matrix

1 Study Coverage
1.1 Introduction to Human Acellular Dermal Matrix Patch: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Human Acellular Dermal Matrix Patch Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Standard Dermal Matrix
1.2.3 Meshed Dermal Matrix
1.3 Market Segmentation by Application
1.3.1 Global Human Acellular Dermal Matrix Patch Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Plastic Surgery
1.3.3 Orthopedics
1.3.4 General Surgery
1.3.5 Anorectal Department
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Acellular Dermal Matrix Patch Revenue Estimates and Forecasts 2020-2031
2.2 Global Human Acellular Dermal Matrix Patch Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Human Acellular Dermal Matrix Patch Sales Estimates and Forecasts 2020-2031
2.4 Global Human Acellular Dermal Matrix Patch Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Human Acellular Dermal Matrix Patch Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Human Acellular Dermal Matrix Patch Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Standard Dermal Matrix Market Size by Manufacturers
3.5.2 Meshed Dermal Matrix Market Size by Manufacturers
3.6 Global Human Acellular Dermal Matrix Patch Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Human Acellular Dermal Matrix Patch Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Human Acellular Dermal Matrix Patch Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Human Acellular Dermal Matrix Patch Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Human Acellular Dermal Matrix Patch Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Human Acellular Dermal Matrix Patch Sales and Revenue by Type (2020-2031)
6.4 North America Human Acellular Dermal Matrix Patch Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Human Acellular Dermal Matrix Patch Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Human Acellular Dermal Matrix Patch Sales and Revenue by Type (2020-2031)
7.4 Europe Human Acellular Dermal Matrix Patch Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Human Acellular Dermal Matrix Patch Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Human Acellular Dermal Matrix Patch Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Human Acellular Dermal Matrix Patch Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Human Acellular Dermal Matrix Patch Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Human Acellular Dermal Matrix Patch Sales and Revenue by Type (2020-2031)
9.4 Central and South America Human Acellular Dermal Matrix Patch Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Human Acellular Dermal Matrix Patch Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Human Acellular Dermal Matrix Patch Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Human Acellular Dermal Matrix Patch Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Human Acellular Dermal Matrix Patch Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 AbbVie (AlloDerm)
11.1.1 AbbVie (AlloDerm) Corporation Information
11.1.2 AbbVie (AlloDerm) Business Overview
11.1.3 AbbVie (AlloDerm) Human Acellular Dermal Matrix Patch Product Models, Descriptions and Specifications
11.1.4 AbbVie (AlloDerm) Human Acellular Dermal Matrix Patch Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 AbbVie (AlloDerm) Human Acellular Dermal Matrix Patch Sales by Product in 2024
11.1.6 AbbVie (AlloDerm) Human Acellular Dermal Matrix Patch Sales by Application in 2024
11.1.7 AbbVie (AlloDerm) Human Acellular Dermal Matrix Patch Sales by Geographic Area in 2024
11.1.8 AbbVie (AlloDerm) Human Acellular Dermal Matrix Patch SWOT Analysis
11.1.9 AbbVie (AlloDerm) Recent Developments
11.2 Zimmer Biomet
11.2.1 Zimmer Biomet Corporation Information
11.2.2 Zimmer Biomet Business Overview
11.2.3 Zimmer Biomet Human Acellular Dermal Matrix Patch Product Models, Descriptions and Specifications
11.2.4 Zimmer Biomet Human Acellular Dermal Matrix Patch Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Zimmer Biomet Human Acellular Dermal Matrix Patch Sales by Product in 2024
11.2.6 Zimmer Biomet Human Acellular Dermal Matrix Patch Sales by Application in 2024
11.2.7 Zimmer Biomet Human Acellular Dermal Matrix Patch Sales by Geographic Area in 2024
11.2.8 Zimmer Biomet Human Acellular Dermal Matrix Patch SWOT Analysis
11.2.9 Zimmer Biomet Recent Developments
11.3 Stryker
11.3.1 Stryker Corporation Information
11.3.2 Stryker Business Overview
11.3.3 Stryker Human Acellular Dermal Matrix Patch Product Models, Descriptions and Specifications
11.3.4 Stryker Human Acellular Dermal Matrix Patch Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Stryker Human Acellular Dermal Matrix Patch Sales by Product in 2024
11.3.6 Stryker Human Acellular Dermal Matrix Patch Sales by Application in 2024
11.3.7 Stryker Human Acellular Dermal Matrix Patch Sales by Geographic Area in 2024
11.3.8 Stryker Human Acellular Dermal Matrix Patch SWOT Analysis
11.3.9 Stryker Recent Developments
11.4 AlloSource
11.4.1 AlloSource Corporation Information
11.4.2 AlloSource Business Overview
11.4.3 AlloSource Human Acellular Dermal Matrix Patch Product Models, Descriptions and Specifications
11.4.4 AlloSource Human Acellular Dermal Matrix Patch Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 AlloSource Human Acellular Dermal Matrix Patch Sales by Product in 2024
11.4.6 AlloSource Human Acellular Dermal Matrix Patch Sales by Application in 2024
11.4.7 AlloSource Human Acellular Dermal Matrix Patch Sales by Geographic Area in 2024
11.4.8 AlloSource Human Acellular Dermal Matrix Patch SWOT Analysis
11.4.9 AlloSource Recent Developments
11.5 ConMed
11.5.1 ConMed Corporation Information
11.5.2 ConMed Business Overview
11.5.3 ConMed Human Acellular Dermal Matrix Patch Product Models, Descriptions and Specifications
11.5.4 ConMed Human Acellular Dermal Matrix Patch Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 ConMed Human Acellular Dermal Matrix Patch Sales by Product in 2024
11.5.6 ConMed Human Acellular Dermal Matrix Patch Sales by Application in 2024
11.5.7 ConMed Human Acellular Dermal Matrix Patch Sales by Geographic Area in 2024
11.5.8 ConMed Human Acellular Dermal Matrix Patch SWOT Analysis
11.5.9 ConMed Recent Developments
11.6 Royal Biologics
11.6.1 Royal Biologics Corporation Information
11.6.2 Royal Biologics Business Overview
11.6.3 Royal Biologics Human Acellular Dermal Matrix Patch Product Models, Descriptions and Specifications
11.6.4 Royal Biologics Human Acellular Dermal Matrix Patch Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Royal Biologics Recent Developments
11.7 Elutia
11.7.1 Elutia Corporation Information
11.7.2 Elutia Business Overview
11.7.3 Elutia Human Acellular Dermal Matrix Patch Product Models, Descriptions and Specifications
11.7.4 Elutia Human Acellular Dermal Matrix Patch Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Elutia Recent Developments
11.8 Beijing Jieya Laifu Biotechnology
11.8.1 Beijing Jieya Laifu Biotechnology Corporation Information
11.8.2 Beijing Jieya Laifu Biotechnology Business Overview
11.8.3 Beijing Jieya Laifu Biotechnology Human Acellular Dermal Matrix Patch Product Models, Descriptions and Specifications
11.8.4 Beijing Jieya Laifu Biotechnology Human Acellular Dermal Matrix Patch Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Beijing Jieya Laifu Biotechnology Recent Developments
11.9 Jiangxi Kexing Biological Engineering
11.9.1 Jiangxi Kexing Biological Engineering Corporation Information
11.9.2 Jiangxi Kexing Biological Engineering Business Overview
11.9.3 Jiangxi Kexing Biological Engineering Human Acellular Dermal Matrix Patch Product Models, Descriptions and Specifications
11.9.4 Jiangxi Kexing Biological Engineering Human Acellular Dermal Matrix Patch Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Jiangxi Kexing Biological Engineering Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Human Acellular Dermal Matrix Patch Industry Chain
12.2 Human Acellular Dermal Matrix Patch Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Human Acellular Dermal Matrix Patch Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Human Acellular Dermal Matrix Patch Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Human Acellular Dermal Matrix Patch Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Human Acellular Dermal Matrix Patch Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Zimmer Biomet
Stryker
AlloSource
ConMed
Royal Biologics
Elutia
AbbVie (AlloDerm)
Beijing Jieya Laifu Biotechnology
Jiangxi Kexing Biological Engineering
List of Tables
 Table 1. Global Human Acellular Dermal Matrix Patch Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Human Acellular Dermal Matrix Patch Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Human Acellular Dermal Matrix Patch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Human Acellular Dermal Matrix Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Human Acellular Dermal Matrix Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Human Acellular Dermal Matrix Patch Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Pcs)
 Table 7. Global Human Acellular Dermal Matrix Patch Sales by Region (2020-2025) & (K Pcs)
 Table 8. Global Human Acellular Dermal Matrix Patch Sales by Region (2026-2031) & (K Pcs)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Human Acellular Dermal Matrix Patch Sales by Manufacturers (2020-2025) & (K Pcs)
 Table 11. Global Human Acellular Dermal Matrix Patch Sales Share by Manufacturers (2020-2025)
 Table 12. Global Human Acellular Dermal Matrix Patch Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Human Acellular Dermal Matrix Patch Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Human Acellular Dermal Matrix Patch by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Acellular Dermal Matrix Patch as of 2024)
 Table 16. Global Human Acellular Dermal Matrix Patch Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Human Acellular Dermal Matrix Patch Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Pcs)
 Table 18. Key Manufacturers Human Acellular Dermal Matrix Patch Manufacturing Base and Headquarters
 Table 19. Global Human Acellular Dermal Matrix Patch Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Human Acellular Dermal Matrix Patch Sales by Type (2020-2025) & (K Pcs)
 Table 23. Global Human Acellular Dermal Matrix Patch Sales by Type (2026-2031) & (K Pcs)
 Table 24. Global Human Acellular Dermal Matrix Patch Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Human Acellular Dermal Matrix Patch Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Human Acellular Dermal Matrix Patch ASP by Type (2020-2031) & (US$/Pcs)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Human Acellular Dermal Matrix Patch Sales by Application (2020-2025) & (K Pcs)
 Table 29. Global Human Acellular Dermal Matrix Patch Sales by Application (2026-2031) & (K Pcs)
 Table 30. Human Acellular Dermal Matrix Patch High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Human Acellular Dermal Matrix Patch Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Human Acellular Dermal Matrix Patch Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Human Acellular Dermal Matrix Patch ASP by Application (2020-2031) & (US$/Pcs)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Human Acellular Dermal Matrix Patch Growth Accelerators and Market Barriers
 Table 37. North America Human Acellular Dermal Matrix Patch Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Human Acellular Dermal Matrix Patch Sales (K Pcs) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Human Acellular Dermal Matrix Patch Growth Accelerators and Market Barriers
 Table 40. Europe Human Acellular Dermal Matrix Patch Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Human Acellular Dermal Matrix Patch Sales (K Pcs) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Human Acellular Dermal Matrix Patch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Human Acellular Dermal Matrix Patch Sales (K Pcs) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Human Acellular Dermal Matrix Patch Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Human Acellular Dermal Matrix Patch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Human Acellular Dermal Matrix Patch Investment Opportunities and Key Challenges
 Table 47. Central and South America Human Acellular Dermal Matrix Patch Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Human Acellular Dermal Matrix Patch Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Human Acellular Dermal Matrix Patch Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. AbbVie (AlloDerm) Corporation Information
 Table 51. AbbVie (AlloDerm) Description and Major Businesses
 Table 52. AbbVie (AlloDerm) Product Models, Descriptions and Specifications
 Table 53. AbbVie (AlloDerm) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 54. AbbVie (AlloDerm) Sales Value Proportion by Product in 2024
 Table 55. AbbVie (AlloDerm) Sales Value Proportion by Application in 2024
 Table 56. AbbVie (AlloDerm) Sales Value Proportion by Geographic Area in 2024
 Table 57. AbbVie (AlloDerm) Human Acellular Dermal Matrix Patch SWOT Analysis
 Table 58. AbbVie (AlloDerm) Recent Developments
 Table 59. Zimmer Biomet Corporation Information
 Table 60. Zimmer Biomet Description and Major Businesses
 Table 61. Zimmer Biomet Product Models, Descriptions and Specifications
 Table 62. Zimmer Biomet Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 63. Zimmer Biomet Sales Value Proportion by Product in 2024
 Table 64. Zimmer Biomet Sales Value Proportion by Application in 2024
 Table 65. Zimmer Biomet Sales Value Proportion by Geographic Area in 2024
 Table 66. Zimmer Biomet Human Acellular Dermal Matrix Patch SWOT Analysis
 Table 67. Zimmer Biomet Recent Developments
 Table 68. Stryker Corporation Information
 Table 69. Stryker Description and Major Businesses
 Table 70. Stryker Product Models, Descriptions and Specifications
 Table 71. Stryker Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 72. Stryker Sales Value Proportion by Product in 2024
 Table 73. Stryker Sales Value Proportion by Application in 2024
 Table 74. Stryker Sales Value Proportion by Geographic Area in 2024
 Table 75. Stryker Human Acellular Dermal Matrix Patch SWOT Analysis
 Table 76. Stryker Recent Developments
 Table 77. AlloSource Corporation Information
 Table 78. AlloSource Description and Major Businesses
 Table 79. AlloSource Product Models, Descriptions and Specifications
 Table 80. AlloSource Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 81. AlloSource Sales Value Proportion by Product in 2024
 Table 82. AlloSource Sales Value Proportion by Application in 2024
 Table 83. AlloSource Sales Value Proportion by Geographic Area in 2024
 Table 84. AlloSource Human Acellular Dermal Matrix Patch SWOT Analysis
 Table 85. AlloSource Recent Developments
 Table 86. ConMed Corporation Information
 Table 87. ConMed Description and Major Businesses
 Table 88. ConMed Product Models, Descriptions and Specifications
 Table 89. ConMed Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 90. ConMed Sales Value Proportion by Product in 2024
 Table 91. ConMed Sales Value Proportion by Application in 2024
 Table 92. ConMed Sales Value Proportion by Geographic Area in 2024
 Table 93. ConMed Human Acellular Dermal Matrix Patch SWOT Analysis
 Table 94. ConMed Recent Developments
 Table 95. Royal Biologics Corporation Information
 Table 96. Royal Biologics Description and Major Businesses
 Table 97. Royal Biologics Product Models, Descriptions and Specifications
 Table 98. Royal Biologics Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 99. Royal Biologics Recent Developments
 Table 100. Elutia Corporation Information
 Table 101. Elutia Description and Major Businesses
 Table 102. Elutia Product Models, Descriptions and Specifications
 Table 103. Elutia Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 104. Elutia Recent Developments
 Table 105. Beijing Jieya Laifu Biotechnology Corporation Information
 Table 106. Beijing Jieya Laifu Biotechnology Description and Major Businesses
 Table 107. Beijing Jieya Laifu Biotechnology Product Models, Descriptions and Specifications
 Table 108. Beijing Jieya Laifu Biotechnology Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 109. Beijing Jieya Laifu Biotechnology Recent Developments
 Table 110. Jiangxi Kexing Biological Engineering Corporation Information
 Table 111. Jiangxi Kexing Biological Engineering Description and Major Businesses
 Table 112. Jiangxi Kexing Biological Engineering Product Models, Descriptions and Specifications
 Table 113. Jiangxi Kexing Biological Engineering Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 114. Jiangxi Kexing Biological Engineering Recent Developments
 Table 115. Key Raw Materials Distribution
 Table 116. Raw Materials Key Suppliers
 Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 118. Milestones in Production Technology Evolution
 Table 119. Distributors List
 Table 120. Market Trends and Market Evolution
 Table 121. Market Drivers and Opportunities
 Table 122. Market Challenges, Risks, and Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources


List of Figures
 Figure 1. Human Acellular Dermal Matrix Patch Product Picture
 Figure 2. Global Human Acellular Dermal Matrix Patch Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Standard Dermal Matrix Product Picture
 Figure 4. Meshed Dermal Matrix Product Picture
 Figure 5. Global Human Acellular Dermal Matrix Patch Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Plastic Surgery
 Figure 7. Orthopedics
 Figure 8. General Surgery
 Figure 9. Anorectal Department
 Figure 10. Others
 Figure 11. Human Acellular Dermal Matrix Patch Report Years Considered
 Figure 12. Global Human Acellular Dermal Matrix Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Human Acellular Dermal Matrix Patch Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Human Acellular Dermal Matrix Patch Revenue Market Share by Region (2020-2031)
 Figure 16. Global Human Acellular Dermal Matrix Patch Sales (2020-2031) & (K Pcs)
 Figure 17. Global Human Acellular Dermal Matrix Patch Sales (CAGR) by Region (2020-2031) (K Pcs)
 Figure 18. Global Human Acellular Dermal Matrix Patch Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Human Acellular Dermal Matrix Patch Sales Volume Market Share in 2024
 Figure 20. Global Human Acellular Dermal Matrix Patch Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Standard Dermal Matrix Revenue Market Share by Manufacturer in 2024
 Figure 23. Meshed Dermal Matrix Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Human Acellular Dermal Matrix Patch Sales Market Share by Type (2020-2031)
 Figure 25. Global Human Acellular Dermal Matrix Patch Revenue Market Share by Type (2020-2031)
 Figure 26. Global Human Acellular Dermal Matrix Patch Sales Market Share by Application (2020-2031)
 Figure 27. Global Human Acellular Dermal Matrix Patch Revenue Market Share by Application (2020-2031)
 Figure 28. North America Human Acellular Dermal Matrix Patch Sales YoY (2020-2031) & (K Pcs)
 Figure 29. North America Human Acellular Dermal Matrix Patch Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) in 2024
 Figure 31. North America Human Acellular Dermal Matrix Patch Sales Volume (K Pcs) by Type (2020- 2031)
 Figure 32. North America Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Human Acellular Dermal Matrix Patch Sales Volume (K Pcs) by Application (2020-2031)
 Figure 34. North America Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Human Acellular Dermal Matrix Patch Sales YoY (2020-2031) & (K Pcs)
 Figure 39. Europe Human Acellular Dermal Matrix Patch Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Human Acellular Dermal Matrix Patch Sales Volume (K Pcs) by Type (2020-2031)
 Figure 42. Europe Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Human Acellular Dermal Matrix Patch Sales Volume (K Pcs) by Application (2020-2031)
 Figure 44. Europe Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 46. France Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Human Acellular Dermal Matrix Patch Sales YoY (2020-2031) & (K Pcs)
 Figure 51. Asia-Pacific Human Acellular Dermal Matrix Patch Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Human Acellular Dermal Matrix Patch Sales Volume (K Pcs) by Type (2020- 2031)
 Figure 54. Asia-Pacific Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Human Acellular Dermal Matrix Patch Sales Volume (K Pcs) by Application (2020-2031)
 Figure 56. Asia-Pacific Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 61. India Human Acellular Dermal Matrix Patch Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Human Acellular Dermal Matrix Patch Sales YoY (2020-2031) & (K Pcs)
 Figure 63. Central and South America Human Acellular Dermal Matrix Patch Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Human Acellular Dermal Matrix Patch Sales Volume (K Pcs) by Type (2021-2031)
 Figure 66. Central and South America Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Human Acellular Dermal Matrix Patch Sales Volume (K Pcs) by Application (2020-2031)
 Figure 68. Central and South America Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Human Acellular Dermal Matrix Patch Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Human Acellular Dermal Matrix Patch Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Human Acellular Dermal Matrix Patch Sales YoY (2020-2031) & (K Pcs)
 Figure 72. Middle East and Africa Human Acellular Dermal Matrix Patch Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Human Acellular Dermal Matrix Patch Sales Volume (K Pcs) by Type (2021-2031)
 Figure 75. South America Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Human Acellular Dermal Matrix Patch Sales Volume (K Pcs) by Application (2020-2031)
 Figure 77. Middle East and Africa Human Acellular Dermal Matrix Patch Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Human Acellular Dermal Matrix Patch Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Human Acellular Dermal Matrix Patch Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Human Acellular Dermal Matrix Patch Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Human Acellular Dermal Matrix Patch Revenue (2020-2025) & (US$ Million)
 Figure 82. Human Acellular Dermal Matrix Patch Industry Chain Mapping
 Figure 83. Regional Human Acellular Dermal Matrix Patch Manufacturing Base Distribution (%)
 Figure 84. Global Human Acellular Dermal Matrix Patch Production Market Share by Region (2020-2031)
 Figure 85. Human Acellular Dermal Matrix Patch Production Process
 Figure 86. Regional Human Acellular Dermal Matrix Patch Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Acellular Dermal Matrix ADM Market Research Report 2024
Global Soft Tissue Acellular Dermal Matrix ADM Market Research Report 2024
Global Human Acellular Dermal Matrix ADM Market Research Report 2024
Global Micronized Acellular Dermal Matrix mADM Market Research Report 2024
Global Human Acellular Dermis Market Research Report 2024
Global Meshed Acellular Dermal Matrix Market Research Report 2024
Extracellular Matrix ECM Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acellular and Dermal Replacement from Human Source Market Research Report 2025
Global Medical Matrix Gel System Market Research Report 2025
Global Dermal Allograft Market Research Report 2024
Breast Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ECM derived Biomaterials Market Research Report 2024
Global Standard Matrigel Matrix Market Research Report 2025
Global Extracellular Matrix ECM Market Research Report 2024
Dental Surgical Tissue Matrix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Collagen Repair Gel Market Research Report 2024
Global Artificial Dermal Matrix Market Research Report 2025
Global Extracellular Matrix Scaffold Market Research Report 2024
Global Matrigel Market Research Report 2025
Global Medical Repair Mesh Market Research Report 2024

RELATED REPORTS

Global Alimentary Tract Implant Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25D19879
Mon Nov 17 00:00:00 UTC 2025

Add to Cart

Global Disposable Surgical Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-0G20452
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Cosmetic Skin Brighteners Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-13I17022
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Skincare Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-38M16890
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions